Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jan 22;3(1):e210003.
doi: 10.1148/rycan.2021210003. eCollection 2021 Jan.

Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now

Gary D Luker  1 , Adeline N Boettcher  1
Affiliations
Editorial

Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now

Gary D Luker et al. Radiol Imaging Cancer. .
No abstract available

PubMed Disclaimer

Comment on

  • Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
    Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, Dutta J, van Bakel H, Aberg J, García-Sastre A, Shah G, Hohl T, Papanicolaou G, Perales MA, Sepkowitz K, Babady NE, Kamboj M. Aydillo T, et al. N Engl J Med. 2020 Dec 24;383(26):2586-2588. doi: 10.1056/NEJMc2031670. Epub 2020 Dec 1. N Engl J Med. 2020. PMID: 33259154 Free PMC article. No abstract available.

References

    1. Luker GD, Boettcher AN. Transitioning to a New Normal after COVID-19: Preparing to Get Back on Track for Cancer Imaging. Radiol Imaging Cancer. Radiological Society of North America; 2020;2(3):e204011 10.1148/rycan.2020204011. - DOI - PMC - PubMed
    1. Deroose CM, Lecouvet FE, Collette L, et al. Impact of the COVID-19 crisis on imaging in oncological trials. Eur J Nucl Med Mol Imaging. Springer Berlin Heidelberg; 2020;47(9):2054–2058 https://pubmed.ncbi.nlm.nih.gov/32533240. - PMC - PubMed
    1. Aydillo T, Gonzalez-Reiche AS, Aslam S, et al. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer. N Engl J Med. Massachusetts Medical Society; 2020;10.1056/NEJMc2031670. - DOI - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. Massachusetts Medical Society; 2020;10.1056/NEJMoa2034577. - DOI - PMC - PubMed
    1. Widge AT, Rouphael NG, Jackson LA, et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med. Massachusetts Medical Society; 2020;10.1056/NEJMc2032195. - DOI - PMC - PubMed

LinkOut - more resources